Understanding the Health Canada Special Access Program

The Health Canada Special Access Program (SAP) is available for doctors to apply for patient access to certain drugs that are not yet approved for sale in Canada. These drugs can be used to treat serious or life-threatening conditions when other treatments have not worked, are not suitable, or are unavailable.

Through the SAP, a drug manufacturer is allowed to sell these drugs when prescribed by a medical doctor for eligible patients.

*SAP authorization is not equivalent to general Health Canada approval of the drug

THE PROCESS

CMAT physicians have experience navigating SAP requests, where clinically appropriate. A physician can discuss whether SAP may be relevant to an individual's circumstances as part of a clinical assessment.

After completing the CMAT Medical and Psychological Intake process, your CMAT Most Responsible Physician (MRP) will discuss if this treatment pathway may be a suitable avenue to explore for Medicine Assisted Therapy treatment.

Application Fee

There is an associated $800 fee to prepare and submit an SAP application, which includes all necessary documentation and follow-up communication with Health Canada. While submitting an application does not guarantee an approval, your CMAT Most Responsible Physciaion will advocate with Health Canada to the best of thier ability. If your request is not approved, your care team will support exploring alternate treatment options.

Conditions considered

for treatment